- Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
-
Jung, Jinhong , Yoon, Sang Min
-
J Liver Cancer. 2018;18(2):94-102. Published online September 30, 2018
-
DOI: https://doi.org/10.17998/jlc.18.2.94
-
-
2,073
Views
-
83
Downloads
-
1
Citation
-
 Abstract
 PDF
- With recent remarkable technological advances in radiation therapy, stereotactic body radiation therapy (SBRT) is regarded as an alternative treatment option for hepatocellular carcinoma (HCC) that is not suitable for curative treatment. Several prospective and retrospective studies on the use of SBRT in patients with HCC showed promising results. Furthermore, on-going prospective studies are examining the role of SBRT as a single ablative modality or a combination treatment in patients with HCC. Here, we summarize previous studies and recent updates and discuss the future perspectives of SBRT for HCC.
-
Citations
Citations to this article as recorded by  - Chemoembolization versus Radiotherapy for Single Hepatocellular Carcinomas of ≤3 cm Unsuitable for Image-Guided Tumor Ablation
Jihye Lim, Euichang Kim, Sehee Kim, So Yeon Kim, Jin Hyoung Kim, Sang Min Yoon, Ju Hyun Shim
Gut and Liver.2024; 18(1): 125. CrossRef
|
E-submission
THE KOREAN LIVER CANCER ASSOCIATION
Follow JLC on Twitter